These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Yu CW; Chen XJ; Lin YH; Tseng YH; Lu CC; Chen BB; Wei SY; Lee JM; Shih TT Eur J Radiol; 2019 Nov; 120():108671. PubMed ID: 31629121 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging in Patients With Hypopharyngeal Squamous Cell Carcinoma. Huang C; Zhang L; Meng Z; Song T; Mukherji SK; Chen X; Lu J; Xian J J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):968-977. PubMed ID: 36399537 [TBL] [Abstract][Full Text] [Related]
6. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481 [TBL] [Abstract][Full Text] [Related]
7. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
8. Relationship between Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566 [TBL] [Abstract][Full Text] [Related]
9. Assessment of serial multi-parametric functional MRI (diffusion-weighted imaging and R2*) with (18)F-FDG-PET in patients with head and neck cancer treated with radiation therapy. Min M; Lee MT; Lin P; Holloway L; Wijesekera Dj; Gooneratne D; Rai R; Xuan W; Fowler A; Forstner D; Liney G Br J Radiol; 2016; 89(1058):20150530. PubMed ID: 26648404 [TBL] [Abstract][Full Text] [Related]
10. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391 [TBL] [Abstract][Full Text] [Related]
11. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
12. The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute. Han M; Kim SY; Lee SJ; Choi JW Medicine (Baltimore); 2015 Nov; 94(47):e2141. PubMed ID: 26632740 [TBL] [Abstract][Full Text] [Related]
13. Geometrical Comparison and Quantitative Evaluation of Li H; Li J; Li F; Zhang Y; Li Y; Guo Y; Xu L Front Oncol; 2021; 11():772428. PubMed ID: 35004291 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma. Husby T; Johansen H; Bogsrud TV; Hustad KV; Evensen BV; Boellaard R; Giskeødegård GF; Fagerli UM; Eikenes L BMC Cancer; 2022 Nov; 22(1):1117. PubMed ID: 36319985 [TBL] [Abstract][Full Text] [Related]
16. Correlations between DW-MRI and Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739 [TBL] [Abstract][Full Text] [Related]
17. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival. Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma. Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204 [TBL] [Abstract][Full Text] [Related]
19. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma. Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447 [TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]